ARTICLE | Distillery Therapeutics
Cancer
October 3, 2018 11:27 PM UTC
Patient sample, cell culture and mouse studies suggest inhibiting UBE2N, UBE2V1, UBE2V2 or FOSL1 could help treat metastatic melanoma. In tumor samples from patients, levels of UBE2N mRNA were higher ...